Services
Early Evidence Strategy
.png){kind=icon}
Building evidence strategies for new healthcare technologies that align with JCA and HTA expectations from the outset.
- HTA readiness through guideline reviews, scientific advice preparation, and JCA PICO simulations ahead of pivotal trial design.
- Early competitive landscape assessment to support development of a data-driven target product profile (TPP). Using evidence synthesis and indirect treatment comparison methods, we generate comparative insights to inform study design and strengthen product positioning.
- Evidence gap analyses to reduce uncertainty and align value claims with HTA expectations and market access strategy.
- Advisory boards to gather expert insights and inform evidence generation strategy across key markets. We recruit balanced boards, facilitate focused discussions, and support alignment between stakeholders.
Other services include:
Success Stories
Stay in touch
Subscribe to Symmetron and stay up to date with recent news and announcements.
Oops! Something went wrong while submitting the form.
8 Devonshire Square,
London, EC2M 4PL, UK
Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UK
Developing a framework for analysing the impact of patient-centred outcomes for achieving reimbursement in the UKEvaluating the cost-effectiveness of a medical device
Evaluating the cost-effectiveness of a medical deviceModelling survival after the clinical trials have ended
Modelling survival after the clinical trials have endedOvercoming limited evidence to gain reimbursement for a blockbuster oncology drug
Overcoming limited evidence to gain reimbursement for a blockbuster oncology drugGaining reimbursement for a drug targeting a rare disease
Gaining reimbursement for a drug targeting a rare diseaseEvaluating the cost-effectiveness of a diagnostic device
Evaluating the cost-effectiveness of a diagnostic deviceOvercoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatments
Overcoming the short-term bias in clinical evidence to compare long-term efficacy of psoriasis treatmentsValidating comparisons of disease treatments in the absence of head-to-head trials
Validating comparisons of disease treatments in the absence of head-to-head trials